Baxter gains amid report in talks to sell kidney care spinoff to Carlyle for $4B
Sascha Schuermann/Getty Images News Baxter International (NYSE:BAX) rose 4% after a report that private equity firm Carlyle Group (CG) is in talks to acquire the kidney care spinoff for more than $4 billion, including debt. The parties entered into talks about the Vantive unit late last month, according to aContinue Reading